(Q51570892)

7 April 2018

title

Reversibility of hyperglycaemia and islet abnormalities in the high fat-fed female ZDF rat model of type 2 diabetes. (English)

1 reference

7 April 2018

0 references

1 reference

Joanne Teague

1

1 reference

7 April 2018

Amie Gyte

2

1 reference

7 April 2018

Joanne E Peel

3

1 reference

7 April 2018

Kimberley C Young

4

1 reference

7 April 2018

Susan J G Loxham

5

1 reference

7 April 2018

Rachel M Mayers

6

1 reference

7 April 2018

Simon M Poucher

7

1 reference

7 April 2018

publication date

14 April 2010

1 reference

7 April 2018

Journal of Pharmacological and Toxicological Methods

published in

1 reference

7 April 2018

volume

63

1 reference

7 April 2018

issue

1

1 reference

7 April 2018

page(s)

15-23

1 reference

7 April 2018

Peroxisome proliferator-activated receptor (PPAR)-alpha agonism prevents the onset of type 2 diabetes in Zucker diabetic fatty rats: A comparison with PPAR gamma agonism.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.04.001

Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.04.001

Effect of dietary fat on the development of non-insulin dependent diabetes mellitus in obese Zucker diabetic fatty male and female rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.04.001

Structural and functional abnormalities in the islets isolated from type 2 diabetic subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.04.001

Profiling of Zucker diabetic fatty rats in their progression to the overt diabetic state.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.04.001

Beta-cell mass dynamics in Zucker diabetic fatty rats. Rosiglitazone prevents the rise in net cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.04.001

Imatinib mesylate reduces endoplasmic reticulum stress and induces remission of diabetes in db/db mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.04.001

Assessing the potential for alpha-glucosidase inhibitors in prediabetic states.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.04.001

The Importance of -Cell Failure in the Development and Progression of Type 2 Diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.04.001

Dynamic changes in {beta}-cell mass and pancreatic insulin during the evolution of nutrition-dependent diabetes in psammomys obesus: impact of glycemic control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.04.001

Anatomical versus functional beta-cell mass in experimental diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.04.001

Structural and functional analysis of pancreatic islets preserved by pioglitazone in db/db mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.04.001

Chronic hyperglycemia, independent of plasma lipid levels, is sufficient for the loss of beta-cell differentiation and secretory function in the db/db mouse model of diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.04.001

UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.04.001

Chronic inhibition of dipeptidyl peptidase-4 with a sitagliptin analog preserves pancreatic beta-cell mass and function in a rodent model of type 2 diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.04.001

Interaction between genetic and dietary factors determines beta-cell function in Psammomys obesus, an animal model of type 2 diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.04.001

Specific and Combined Effects of Insulin and Glucose on Functional Pancreatic β-Cell Mass in Vivo in Adult Rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.04.001

Role of apoptosis in failure of beta-cell mass compensation for insulin resistance and beta-cell defects in the male Zucker diabetic fatty rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.04.001

Minireview: Secondary beta-cell failure in type 2 diabetes--a convergence of glucotoxicity and lipotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.04.001

The GK rat beta-cell: a prototype for the diseased human beta-cell in type 2 diabetes?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.04.001

Rosiglitazone prevents the onset of hyperglycaemia and proteinuria in the Zucker diabetic fatty rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.04.001

GLP-1 derivative liraglutide in rats with beta-cell deficiencies: influence of metabolic state on beta-cell mass dynamics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.04.001

Dynamics of insulin sensitivity, -cell function, and -cell mass during the development of diabetes in fa/fa rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.04.001

The dual peroxisome proliferator-activated receptor alpha/gamma activator muraglitazar prevents the natural progression of diabetes in db/db mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.04.001

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.04.001

Improvement of glucose tolerance in Zucker diabetic fatty rats by long-term treatment with the dipeptidyl peptidase inhibitor P32/98: comparison with and combination with rosiglitazone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.04.001

Matrix metalloproteinases contribute to insulin insufficiency in Zucker diabetic fatty rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2010.04.001

10.1016/J.VASCN.2010.04.001

7 January 2021

Identifiers

DOI

1 reference

7 April 2018

1 reference

7 April 2018